mtb Search Results


nattroltm mtb verification panel  (ZeptoMetrix corporation)
93
ZeptoMetrix corporation nattroltm mtb verification panel
Nattroltm Mtb Verification Panel, supplied by ZeptoMetrix corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nattroltm mtb verification panel/product/ZeptoMetrix corporation
Average 93 stars, based on 1 article reviews
nattroltm mtb verification panel - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
prdm2  (Proteintech)
93
Proteintech prdm2
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
Prdm2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prdm2/product/Proteintech
Average 93 stars, based on 1 article reviews
prdm2 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
beijing strain, hn878  (BEI Resources)
90
BEI Resources beijing strain, hn878
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
Beijing Strain, Hn878, supplied by BEI Resources, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/beijing strain, hn878/product/BEI Resources
Average 90 stars, based on 1 article reviews
beijing strain, hn878 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
truenat mtb  (MolBio Diagnostics)
90
MolBio Diagnostics truenat mtb
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
Truenat Mtb, supplied by MolBio Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/truenat mtb/product/MolBio Diagnostics
Average 90 stars, based on 1 article reviews
truenat mtb - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
smart sure™ mtb multidrug-resistant-tb (mdr-tb) kits  (Genetix Biotech)
90
Genetix Biotech smart sure™ mtb multidrug-resistant-tb (mdr-tb) kits
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
Smart Sure™ Mtb Multidrug Resistant Tb (Mdr Tb) Kits, supplied by Genetix Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/smart sure™ mtb multidrug-resistant-tb (mdr-tb) kits/product/Genetix Biotech
Average 90 stars, based on 1 article reviews
smart sure™ mtb multidrug-resistant-tb (mdr-tb) kits - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mtb-infected macrophages  (Philips Healthcare)
90
Philips Healthcare mtb-infected macrophages
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
Mtb Infected Macrophages, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtb-infected macrophages/product/Philips Healthcare
Average 90 stars, based on 1 article reviews
mtb-infected macrophages - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nonduplicate mtb strains  (Tropical Disease Foundation Inc)
90
Tropical Disease Foundation Inc nonduplicate mtb strains
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
Nonduplicate Mtb Strains, supplied by Tropical Disease Foundation Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonduplicate mtb strains/product/Tropical Disease Foundation Inc
Average 90 stars, based on 1 article reviews
nonduplicate mtb strains - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
m. tuberculosis isolates  (MiddleBrook Pharmaceuticals)
90
MiddleBrook Pharmaceuticals m. tuberculosis isolates
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
M. Tuberculosis Isolates, supplied by MiddleBrook Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m. tuberculosis isolates/product/MiddleBrook Pharmaceuticals
Average 90 stars, based on 1 article reviews
m. tuberculosis isolates - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
wt mtb ml617  (MiddleBrook Pharmaceuticals)
90
MiddleBrook Pharmaceuticals wt mtb ml617
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
Wt Mtb Ml617, supplied by MiddleBrook Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wt mtb ml617/product/MiddleBrook Pharmaceuticals
Average 90 stars, based on 1 article reviews
wt mtb ml617 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
177 mtb leads  (Glaxo Smith)
90
Glaxo Smith 177 mtb leads
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
177 Mtb Leads, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/177 mtb leads/product/Glaxo Smith
Average 90 stars, based on 1 article reviews
177 mtb leads - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
realtime mtb assay  (Abbott Laboratories)
90
Abbott Laboratories realtime mtb assay
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
Realtime Mtb Assay, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/realtime mtb assay/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
realtime mtb assay - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
realtime mtb rif/inh resistance amplification reagents  (Abbott Laboratories)
90
Abbott Laboratories realtime mtb rif/inh resistance amplification reagents
Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and <t>PRDM2</t> proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.
Realtime Mtb Rif/Inh Resistance Amplification Reagents, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/realtime mtb rif/inh resistance amplification reagents/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
realtime mtb rif/inh resistance amplification reagents - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and PRDM2 proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Article Title: Syringetin relieves bone cancer pain in rats induced by breast cancer cells through the ESR1/PRDM2 axis.

doi: 10.4196/kjpp.24.303

Figure Lengend Snippet: Fig. 3. Syringetin inhibited the malignant characteristics of rat breast cancer cells SHZ-88 and the expression of ESR1 protein. (A) Cell viability was detected by CCK8 after SHZ-88 cells were intervened with 2.5 μM, 5 μM, and 10 μM Syringetin. (B) TUNEL staining was employed to detect the cell apoptosis under the intervention of 10 μM Syringetin (200×). (C) Transwell was applied to detect cell migration under the intervention of 10 μM Syringetin. (D) WB detection of the expression of ESR1 and PRDM2 proteins in cells under the intervention of 10 μM Syringetin. N = 3 replicates/group. ESR1, estrogen receptor 1; CCK8, Cell-Counting-Kit-8; TUNEL, Terminal transferase dUTP Nick End Labeling; WB, Western blotting; DAPI, 4,6-diamidine- 2-phenylindole dihydrochloride; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Control.

Article Snippet: Then, first antibodies were added onto the membrane, including ESR1 (21244-1-AP, 1:2,000, Proteintech), PRDM2 (27718-1-AP, 1:500, Proteintech) and β-actin (AWA80002, 1:5,000, Abiowell).

Techniques: Expressing, TUNEL Assay, Staining, Migration, Cell Counting, End Labeling, Western Blot, Control

Fig. 4. Syringetin inhibited ESR1 expression and alleviated bone cancer pain (BCP) induced by breast cancer cells in rats. 4 × 10 4 SHZ-88 cells were implanted into the bone marrow cavity of the hind tibia of rats, which was administered orally with 15 mg/kg/day Syringetin for 21 days. (A) Histopathological status of rat tibia tissue stained with HE (100× and 400×). (B) AS scores and PWT scores. (C) WB detection of ESR1 and PRDM2 ex- pression in tibial bone marrow tissue. N = 9 replicates/group. ESR1, estrogen receptor 1; HE, hematoxylin-eosin; AS, Ambulatory score; PWT, paw with- drawal threshold; WB, Western blotting; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Sham, #p < 0.05 vs. BCP.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Article Title: Syringetin relieves bone cancer pain in rats induced by breast cancer cells through the ESR1/PRDM2 axis.

doi: 10.4196/kjpp.24.303

Figure Lengend Snippet: Fig. 4. Syringetin inhibited ESR1 expression and alleviated bone cancer pain (BCP) induced by breast cancer cells in rats. 4 × 10 4 SHZ-88 cells were implanted into the bone marrow cavity of the hind tibia of rats, which was administered orally with 15 mg/kg/day Syringetin for 21 days. (A) Histopathological status of rat tibia tissue stained with HE (100× and 400×). (B) AS scores and PWT scores. (C) WB detection of ESR1 and PRDM2 ex- pression in tibial bone marrow tissue. N = 9 replicates/group. ESR1, estrogen receptor 1; HE, hematoxylin-eosin; AS, Ambulatory score; PWT, paw with- drawal threshold; WB, Western blotting; PRDM2, positive regulatory domain zinc finger protein2. *p < 0.05 vs. Sham, #p < 0.05 vs. BCP.

Article Snippet: Then, first antibodies were added onto the membrane, including ESR1 (21244-1-AP, 1:2,000, Proteintech), PRDM2 (27718-1-AP, 1:500, Proteintech) and β-actin (AWA80002, 1:5,000, Abiowell).

Techniques: Expressing, Staining, Western Blot